Annual FCF:
$110.10M+$106.28M(+2782.88%)Summary
- As of today, ADMA annual free cash flow is $110.10 million, with the most recent change of +$106.28 million (+2782.88%) on December 31, 2024.
- During the last 3 years, ADMA annual free cash flow has risen by +$235.98 million (+187.46%).
- ADMA annual free cash flow is now at all-time high.
Performance
ADMA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$18.61M+$43.01M(+176.29%)Summary
- As of today, ADMA quarterly free cash flow is $18.61 million, with the most recent change of +$43.01 million (+176.29%) on June 30, 2025.
- Over the past year, ADMA quarterly free cash flow has dropped by -$24.67 million (-57.00%).
- ADMA quarterly free cash flow is now -60.79% below its all-time high of $47.47 million, reached on December 31, 2024.
Performance
ADMA Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$65.61M-$24.67M(-27.32%)Summary
- As of today, ADMA TTM free cash flow is $65.61 million, with the most recent change of -$24.67 million (-27.32%) on June 30, 2025.
- Over the past year, ADMA TTM free cash flow has dropped by -$505.30 thousand (-0.76%).
- ADMA TTM free cash flow is now -40.40% below its all-time high of $110.10 million, reached on December 31, 2024.
Performance
ADMA TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ADMA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +2782.9% | -57.0% | -0.8% |
| 3Y3 Years | +187.5% | +211.0% | +166.3% |
| 5Y5 Years | +237.6% | +173.1% | +165.5% |
ADMA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +187.5% | -60.8% | +176.3% | -40.4% | +166.0% |
| 5Y | 5-Year | at high | +187.5% | -60.8% | +150.1% | -40.4% | +148.6% |
| All-Time | All-Time | at high | +187.5% | -60.8% | +150.1% | -40.4% | +148.6% |
ADMA Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $18.61M(+176.3%) | $65.61M(-27.3%) |
| Mar 2025 | - | -$24.39M(-151.4%) | $90.28M(-18.0%) |
| Dec 2024 | $110.10M(+2782.9%) | $47.47M(+98.4%) | $110.10M(+39.7%) |
| Sep 2024 | - | $23.93M(-44.7%) | $78.82M(+19.2%) |
| Jun 2024 | - | $43.28M(+1045.0%) | $66.12M(+315.7%) |
| Mar 2024 | - | -$4.58M(-128.3%) | $15.91M(+316.5%) |
| Dec 2023 | $3.82M(+105.2%) | $16.19M(+44.2%) | $3.82M(+116.3%) |
| Sep 2023 | - | $11.23M(+262.0%) | -$23.50M(+54.3%) |
| Jun 2023 | - | -$6.93M(+58.4%) | -$51.39M(+16.1%) |
| Mar 2023 | - | -$16.67M(-49.8%) | -$61.23M(+16.6%) |
| Dec 2022 | -$73.42M(+41.7%) | -$11.13M(+33.2%) | -$73.42M(+26.2%) |
| Sep 2022 | - | -$16.67M(+0.6%) | -$99.43M(-0.5%) |
| Jun 2022 | - | -$16.77M(+41.9%) | -$98.97M(+16.8%) |
| Mar 2022 | - | -$28.86M(+22.3%) | -$118.94M(+5.5%) |
| Dec 2021 | -$125.88M(-9.7%) | -$37.14M(-129.3%) | -$125.88M(-1.1%) |
| Sep 2021 | - | -$16.20M(+55.9%) | -$124.56M(+7.8%) |
| Jun 2021 | - | -$36.74M(-2.6%) | -$135.09M(-9.1%) |
| Mar 2021 | - | -$35.80M(+0.0%) | -$123.81M(-7.9%) |
| Dec 2020 | -$114.73M(-43.4%) | -$35.82M(-34.0%) | -$114.73M(-14.5%) |
| Sep 2020 | - | -$26.74M(-5.0%) | -$100.16M(-1.1%) |
| Jun 2020 | - | -$25.45M(+4.7%) | -$99.02M(-7.2%) |
| Mar 2020 | - | -$26.72M(-25.8%) | -$92.33M(-15.4%) |
| Dec 2019 | -$80.01M(-23.5%) | -$21.25M(+17.0%) | -$80.01M(-2.1%) |
| Sep 2019 | - | -$25.60M(-36.5%) | -$78.37M(-19.6%) |
| Jun 2019 | - | -$18.76M(-30.3%) | -$65.54M(-5.4%) |
| Mar 2019 | - | -$14.40M(+26.6%) | -$62.19M(+4.0%) |
| Dec 2018 | -$64.77M | -$19.61M(-53.5%) | -$64.77M(-7.0%) |
| Sep 2018 | - | -$12.77M(+17.1%) | -$60.53M(-4.2%) |
| Jun 2018 | - | -$15.41M(+9.3%) | -$58.07M(-12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$16.98M(-10.5%) | -$51.53M(-29.0%) |
| Dec 2017 | -$39.95M(-117.8%) | -$15.37M(-49.1%) | -$39.95M(-41.6%) |
| Sep 2017 | - | -$10.31M(-16.2%) | -$28.20M(-24.9%) |
| Jun 2017 | - | -$8.87M(-64.2%) | -$22.58M(-21.7%) |
| Mar 2017 | - | -$5.40M(-49.1%) | -$18.56M(-1.2%) |
| Dec 2016 | -$18.34M(-18.8%) | -$3.62M(+22.7%) | -$18.34M(+2.4%) |
| Sep 2016 | - | -$4.69M(+3.2%) | -$18.79M(-12.0%) |
| Jun 2016 | - | -$4.84M(+6.6%) | -$16.79M(-2.4%) |
| Mar 2016 | - | -$5.19M(-27.3%) | -$16.39M(-6.2%) |
| Dec 2015 | -$15.44M(+9.3%) | -$4.07M(-51.9%) | -$15.44M(-4.1%) |
| Sep 2015 | - | -$2.68M(+39.8%) | -$14.83M(+7.4%) |
| Jun 2015 | - | -$4.45M(-5.2%) | -$16.01M(+0.6%) |
| Mar 2015 | - | -$4.24M(-22.4%) | -$16.11M(+5.4%) |
| Dec 2014 | -$17.03M(-53.6%) | -$3.46M(+10.5%) | -$17.03M(-3.0%) |
| Sep 2014 | - | -$3.86M(+15.2%) | -$16.53M(-10.9%) |
| Jun 2014 | - | -$4.55M(+11.6%) | -$14.91M(-13.9%) |
| Mar 2014 | - | -$5.15M(-73.7%) | -$13.10M(-18.1%) |
| Dec 2013 | -$11.08M(-57.8%) | -$2.97M(-32.3%) | -$11.08M(-11.3%) |
| Sep 2013 | - | -$2.24M(+18.0%) | -$9.96M(-1.2%) |
| Jun 2013 | - | -$2.74M(+12.9%) | -$9.85M(-21.4%) |
| Mar 2013 | - | -$3.14M(-70.5%) | -$8.11M(-16.4%) |
| Dec 2012 | -$7.02M(-390.6%) | -$1.84M(+13.5%) | -$6.97M(-36.0%) |
| Sep 2012 | - | -$2.13M(-113.5%) | -$5.12M(-71.1%) |
| Jun 2012 | - | -$996.90K(+50.1%) | -$3.00M(-49.9%) |
| Mar 2012 | - | -$2.00M(>-9900.0%) | -$2.00M(-9283.6%) |
| Dec 2011 | -$1.43M(+70.3%) | - | - |
| Mar 2011 | - | -$3900.00(+56.7%) | -$21.30K(-22.4%) |
| Dec 2010 | -$4.82M(>-9900.0%) | -$9000.00(-7.1%) | -$17.40K(-107.1%) |
| Sep 2010 | - | -$8400.00 | -$8400.00 |
| Jun 2010 | -$19.70K | - | - |
FAQ
- What is ADMA Biologics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. annual free cash flow year-on-year change?
- What is ADMA Biologics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. quarterly free cash flow year-on-year change?
- What is ADMA Biologics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. TTM free cash flow year-on-year change?
What is ADMA Biologics, Inc. annual free cash flow?
The current annual free cash flow of ADMA is $110.10M
What is the all-time high annual free cash flow for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high annual free cash flow is $110.10M
What is ADMA Biologics, Inc. annual free cash flow year-on-year change?
Over the past year, ADMA annual free cash flow has changed by +$106.28M (+2782.88%)
What is ADMA Biologics, Inc. quarterly free cash flow?
The current quarterly free cash flow of ADMA is $18.61M
What is the all-time high quarterly free cash flow for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high quarterly free cash flow is $47.47M
What is ADMA Biologics, Inc. quarterly free cash flow year-on-year change?
Over the past year, ADMA quarterly free cash flow has changed by -$24.67M (-57.00%)
What is ADMA Biologics, Inc. TTM free cash flow?
The current TTM free cash flow of ADMA is $65.61M
What is the all-time high TTM free cash flow for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high TTM free cash flow is $110.10M
What is ADMA Biologics, Inc. TTM free cash flow year-on-year change?
Over the past year, ADMA TTM free cash flow has changed by -$505.30K (-0.76%)